Background: Plantar fasciitis (PF) is the one of the commonest causes of heel pain is middle age groups. In the management of PF, now a day's activated Platelet-rich Plasma (PRP)is growing popularity. We here try to assess the safety and effectiveness of activated PRP in the management of PF.
Materials & Methods: We have included 10 patients with PF who were given activated PRP and ensured regular follow-up. Functional outcomes and pain severity were measured by using Visual Analogue Scale (VAS) and AOFAS scale. Inclusion Criteria-age between 18 t 60years, sore around the insertion of the plantar fascia on calcaneus, clinical features for about 6 to 9 months, can easily understand the procedure and signup in the informed consent, minimum 6 weeks gap between steroid injection and 4 weeks from local anesthetics injection, without NSAID'S free period before procedure. AOFAS is more than 30, VAS score more than 5.Exclusion Criteria: Operation done before in the same ankle, pain feels anywhere other than at the insertion of the plantar fascia on calcaneus, connective tissue diseases, uncontrolled diabetes, any inflammatory condition in the procedure site, previously injured Achilles tendon, allergy to calcium gluconate injection, history of collagen diseases or rheumatic diseases, Paget's diseases, thrombocytopenia.
Results: Follow-up was taken on 4th, 6th week, 2nd and 3rd months. Both VAS and AOFAS score were improved significantly. Results were not altered indifferent age and sex. Pain severity was reduced to patient's own satisfactory level.
Conclusion: From our study we concluded that activated PRP is relatively safe, cost effective, and convenient than other available treatment modalities.